Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03759912
Other study ID # 2018-07-008
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date November 20, 2018
Est. completion date August 7, 2021

Study information

Verified date May 2023
Source Keimyung University Dongsan Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The electrical isolation of the pulmonary veins (PVI) is the cornerstone of current ablation techniques for the treatment of atrial fibrillation (AF) because the PV is the most common trigger of AF. Wide bi-antral circumferential ablation (WACA) is more effective than segmental PV isolation in achieving freedom from total atrial tachyarrhythmia recurrence at long-term follow-up. Therefore, it is widely accepted as initial ablation strategy. However, the WACA technique requires a much larger number of ablation and higher energy to achieve complete isolation because of thick atrial myocardial sleeves with multiple muscle layers present in most of the PV antrum, which is less likely to achieve homogenous transmural lesions in the entire circumference with the currently available ablation technologies. Meanwhile, muscular discontinuities and abrupt changes of the fiber orientation in human PV-Left atrium (LA) junction are previously reported, and electrical PV isolation can usually be achieved without complete circumferential ablation. However, the current electroanatomical mapping (EAM) system has a limitation to understand the complex relationship of PV-LA junction mainly due to relatively low resolution. The Rhythmia mapping system (BostonScientific, Inc, Cambridge, MA) is a new system provides ultra-high-resolution EAM using a small basket array of 64 electrodes (IntellaMap Orion, Boston Scientific). Owing to better resolution, this new system capable of rapidly and accurately identify critical isthmuses and low-voltage regions of interest and also allows automatic acquisition and accurate annotation of the electrograms, without the need for manual correction. In this context, we hypothesized that rapid and precise identification of activation pattern of PV-LA junction by Rhythmia system could allow complete, durable electrical isolation of PVs without circumferential antral ablation.


Recruitment information / eligibility

Status Terminated
Enrollment 75
Est. completion date August 7, 2021
Est. primary completion date August 5, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria: 1. Age over 20 years old and under 80 years old 2. Patients with non-valvular paroxysmal atrial fibrillation 3. Patients having atrial fibrillation even after receiving continued treatment with at least 1 antiarrhythmic drug for more than 6 weeks 4. Patients who could have informed consent 5. Patients who are available for a follow-up of more than at least three months after the catheter ablation Exclusion Criteria: 1. Patients unsuitable for catheter ablation due to a previous history of pulmonary surgery or structural heart disease 2. Patients who cannot receive standard treatments such as anticoagulation therapy needed before the radiofrequency catheter ablation 3. Patients in the subject group vulnerable to a clinical study 4. Patients who had undergone a prior catheter ablation for atrial fibrillation

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Korea, Republic of Keimyung University Dongsan Medical Center Daegu

Sponsors (2)

Lead Sponsor Collaborator
Keimyung University Dongsan Medical Center Boston Scientific Corporation

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Atrial arrhythmia recurrence recurrence of atrial tachyarrhythmia after the index procedure one year
Secondary acute pulmonary vein isolation rate Percentage of patients who are able to obtain pulmonary vein isolation during the procedure During procedure
Secondary acute pulmonary vein reconnection rate Percentage of patients who achieve pulmonary vein isolation during the procedure but have PV reconnection within the procedure During procedure
Secondary percentage of ablation area in the antrum Area of pulmonary vein antrum ablated to obtain pulmonary vein isolation During procedure
Secondary Procedural outcome procedure time in minute During procedure
Secondary Procedural outcome fluoroscopic time in minute During procedure
Secondary Procedural outcome total ablation time in minute During procedure
Secondary Procedural outcome procedural complications - number of patients who experienced complications During procedure
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Terminated NCT04115735 - His Bundle Recording From Subclavian Vein
Completed NCT04571385 - A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF) Phase 2
Completed NCT05366803 - Women's Health Initiative Silent Atrial Fibrillation Recording Study N/A
Completed NCT02864758 - Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
Recruiting NCT05442203 - Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease N/A
Completed NCT05599308 - Evaluation of Blood Pressure Monitor With AFib Screening Feature N/A
Completed NCT03790917 - Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
Enrolling by invitation NCT05890274 - Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO N/A
Recruiting NCT05316870 - Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation N/A
Recruiting NCT05266144 - Atrial Fibrillation Patients Treated With Catheter Ablation
Not yet recruiting NCT06023784 - The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Recruiting NCT04092985 - Smart Watch iECG for the Detection of Cardiac Arrhythmias
Completed NCT04087122 - Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures N/A
Completed NCT06283654 - Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
Recruiting NCT05416086 - iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT04546763 - Study Watch AF Detection At Home
Completed NCT03761394 - Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke N/A